Extract from the above information

It exerts antiplatelet and vasodilator effects by inhibiting the activity of phosphodiesterase in platelets and vascular smooth muscle, increasing the cAMP concentration in platelets and smooth muscle; inhibiting the initial and secondary platelet aggregation and release reactions induced by ADP, adrenaline, collagen and arachidonic acid; not interfering with the synthesis of vascular protective prostacyclin by vascular endothelial cells; and increasing tissue blood flow in the foot and gastrocnemius muscles in patients with chronic arterial occlusion, thereby increasing the lower limb blood pressure index, skin blood flow and skin temperature of the limbs, and improving intermittent claudication.

This product belongs to the quinolone antibacterial drug, which is the levorotatory form of ofloxacin. Its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase and the replication of bacterial DNA. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect, and has good antibacterial effect on most Enterobacteriaceae, some Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

It has the effect of constricting the capillaries in the upper respiratory tract, eliminating congestion in the nasopharyngeal mucosa and alleviating symptoms of nasal congestion.

It is an antihistamine with strong antihistamine and sedative effects, which can further alleviate symptoms such as nasal congestion and runny nose caused by colds.